Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Miranda

Showing results (351-360 of 361) with videos related to

Pageof 37
Sort By:
Scientific Reports|April 18, 2024
Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV‑2 Mpro)Pedro Henrique R de A Azevedo, Priscila G Camargo, Larissa E C Constant, et al.
Plos Pathogens|December 16, 2020
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediatorsSuelen Silva Gomes Dias, Vinicius Cardoso Soares, André C Ferreira, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|July 22, 2020
Diagnostic groups and short-term outcomes in suspected COVID-19 cases treated in an emergency departmentF Javier Martín-Sánchez, Juan González Del Castillo, Adrián Valls Carbó, et al.
Cells|September 28, 2021
Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2Juliana G Melgaço, Tamiris Azamor, Andréa M V Silva, et al.
European Geriatric Medicine|July 17, 2020
Clinical presentation and outcome across age categories among patients with COVID-19 admitted to a Spanish Emergency DepartmentF Javier Martín-Sánchez, Enrique Del Toro, Eduardo Cardassay, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|March 11, 2022
Procalcitonin concentration in the emergency department predicts 30-day mortality in COVID-19 better than the lymphocyte count, the neutrophil-tolymphocyte ratio, or the C-reactive protein levelPedro López-Ayala, Ana Alcaraz-Serna, Adrián Valls Carbó, et al.
Viruses|November 27, 2024
Benzocarbazoledinones as SARS-CoV-2 Replication Inhibitors: Synthesis, Cell-Based Studies, Enzyme Inhibition, Molecular Modeling, and Pharmacokinetics InsightsLuana G de Souza, Eduarda A Penna, Alice S Rosa, et al.
Journal of General Internal Medicine|July 9, 2021
Socio-Demographic Health Determinants Are Associated with Poor Prognosis in Spanish Patients Hospitalized with COVID-19F Javier Martín-Sánchez, Adrián Valls Carbó, Òscar Miró, et al.
Arquivos Brasileiros De Cardiologia|September 18, 2013
[First guidelines of the Brazilian Society of Cardiology on processes and skills for education in cardiology in Brazil], M R de Sousa, G S Feitosa, et al.
Arquivos Brasileiros De Cardiologia|September 6, 2012
First Brazilian position on resistant hypertensionAlexandre Alessi, Andrea Araújo Brandão, Antonio Coca, et al.
Pageof 37

Showing results (351-360 of 361) with videos related to

Sort By:
Pageof 37
Scientific Reports|April 18, 2024
Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV‑2 Mpro)Pedro Henrique R de A Azevedo, Priscila G Camargo, Larissa E C Constant, et al.
Plos Pathogens|December 16, 2020
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediatorsSuelen Silva Gomes Dias, Vinicius Cardoso Soares, André C Ferreira, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|July 22, 2020
Diagnostic groups and short-term outcomes in suspected COVID-19 cases treated in an emergency departmentF Javier Martín-Sánchez, Juan González Del Castillo, Adrián Valls Carbó, et al.
Cells|September 28, 2021
Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2Juliana G Melgaço, Tamiris Azamor, Andréa M V Silva, et al.
European Geriatric Medicine|July 17, 2020
Clinical presentation and outcome across age categories among patients with COVID-19 admitted to a Spanish Emergency DepartmentF Javier Martín-Sánchez, Enrique Del Toro, Eduardo Cardassay, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|March 11, 2022
Procalcitonin concentration in the emergency department predicts 30-day mortality in COVID-19 better than the lymphocyte count, the neutrophil-tolymphocyte ratio, or the C-reactive protein levelPedro López-Ayala, Ana Alcaraz-Serna, Adrián Valls Carbó, et al.
Viruses|November 27, 2024
Benzocarbazoledinones as SARS-CoV-2 Replication Inhibitors: Synthesis, Cell-Based Studies, Enzyme Inhibition, Molecular Modeling, and Pharmacokinetics InsightsLuana G de Souza, Eduarda A Penna, Alice S Rosa, et al.
Journal of General Internal Medicine|July 9, 2021
Socio-Demographic Health Determinants Are Associated with Poor Prognosis in Spanish Patients Hospitalized with COVID-19F Javier Martín-Sánchez, Adrián Valls Carbó, Òscar Miró, et al.
Arquivos Brasileiros De Cardiologia|September 18, 2013
[First guidelines of the Brazilian Society of Cardiology on processes and skills for education in cardiology in Brazil], M R de Sousa, G S Feitosa, et al.
Arquivos Brasileiros De Cardiologia|September 6, 2012
First Brazilian position on resistant hypertensionAlexandre Alessi, Andrea Araújo Brandão, Antonio Coca, et al.
Pageof 37